Bikui Zhang
Overview
Explore the profile of Bikui Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang J, Hou X, Zhou N, Su N, Wei S, Yang Y, et al.
Cardiovasc Drugs Ther
. 2025 Jan;
PMID: 39808382
Purpose: Doxorubicin (Dox) is a classic anthracycline chemotherapy drug with cause cumulative and dose-dependent cardiotoxicity. This study aimed to investigate the potential role and molecular mechanism of phenylacetylglutamine (PAGln), a...
2.
Lin C, Ma R, Zeng X, Zhang B, Cao T, Jiao S, et al.
Front Pharmacol
. 2024 Dec;
15:1423214.
PMID: 39669197
Background: High-dose methotrexate (HD-MTX) is commonly employed in the treatment of malignant tumors in children and young adults due to its distinctive therapeutic efficacy. Nonetheless, the systemic exposure to MTX...
3.
Xiao J, Chen B, Chen L, Wang Q, Tan S, Yuan H, et al.
Int J Med Inform
. 2024 Dec;
195:105737.
PMID: 39626597
Background: Type 2 diabetes (T2D) has become a serious health threat globally. However, the existing approaches for diabetes prediction mainly had difficulty in addressing multiple time-series features. This study aims...
4.
Liu S, Yang Y, Hou X, Zhou N, Zhang B, Li W
Pharmacol Res
. 2024 Nov;
210:107514.
PMID: 39577754
The maintenance of cardiac homeostasis necessitates proper protein turnover, which is regulated by the ubiquitin-proteasome system. F-box proteins are one type of E3 ubiquitin ligases, and accumulating evidence suggests that...
5.
Yang J, Kang H, Liu Y, Lu S, Wu H, Zhang B, et al.
Adv Sci (Weinh)
. 2024 Nov;
12(2):e2409207.
PMID: 39540242
Transplantation remains the definitive treatment for end-stage organ failures, but its efficacy is frequently compromised by immune rejection. This study introduces a novel strategy by utilizing tumor-derived exosomes from B16-F10...
6.
Xiao J, Huang S, Wang Q, Tan S, Chen L, Yuan H, et al.
J Epidemiol Glob Health
. 2024 May;
14(3):974-986.
PMID: 38780894
Background: Although physician-pharmacist collaborative clinics for diabetes management have been shown to be effective and cost-effective worldwide, there is limited understanding of the factors that influence their sustainable implementation. This...
7.
Lin C, Zhang S, Yang P, Zhang B, Guo W, Wu R, et al.
Schizophrenia (Heidelb)
. 2024 May;
10(1):52.
PMID: 38760414
The prolonged usage of atypical antipsychotic drugs (AAPD) among individuals with schizophrenia often leads to metabolic side effects such as dyslipidemia. These effects not only limit one's selection of AAPD...
8.
Liang T, Lin C, Ning H, Qin F, Zhang B, Zhao Y, et al.
Front Pharmacol
. 2024 Apr;
15:1349043.
PMID: 38628642
Valproic acid (VPA) stands as one of the most frequently prescribed medications in children with newly diagnosed epilepsy. Despite its infrequent adverse effects within therapeutic range, prolonged VPA usage may...
9.
Xie S, Zhou N, Su N, Xiao Z, Wei S, Yang Y, et al.
Noncoding RNA Res
. 2024 Apr;
9(3):744-758.
PMID: 38577019
Trastuzumab-induced cardiotoxicity (TIC) is a common and serious disease with abnormal cardiac function. Accumulating evidence has indicated certain non-coding RNAs (ncRNAs), functioning as competing endogenous RNAs (ceRNAs), impacting the progression...
10.
Liu S, Liu J, Su N, Wei S, Xie N, Li X, et al.
Cardiovasc Drugs Ther
. 2024 Feb;
PMID: 38400848
Purpose: Doxorubicin (Dox) is clinically limited due to its dose-dependent cardiotoxicity. Andrographolide (Andro) has been confirmed to exert cardiovascular protective activities. This study aimed to investigate protective effects of Andro...